2017
DOI: 10.1016/j.resp.2017.04.006
|View full text |Cite
|
Sign up to set email alerts
|

The acute cardiorespiratory effects of centrally injected arachidonic acid; the mediation of prostaglandin E, D and F 2α

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 36 publications
0
11
0
Order By: Relevance
“…Previous study in rats demonstrated that arachidonic acid, a PUFA, increases PnormalO2 , suggesting a role for fatty acids in respiratory control (Erkan et al . ).…”
Section: Discussionmentioning
confidence: 97%
“…Previous study in rats demonstrated that arachidonic acid, a PUFA, increases PnormalO2 , suggesting a role for fatty acids in respiratory control (Erkan et al . ).…”
Section: Discussionmentioning
confidence: 97%
“…Some of the concentration-QTcF models for parent OBE002 (models both and OBE022; Table 2) tended to indicate a nonsignificant negative slope. An effect on cardiac function of exposure to the FP antagonists OBE002 or its parent OBE022 could be excluded despite the reported action of FP agonists on cardiac function in vitro 8,9,11,[30][31][32] and reports of blood pressure elevation in response to topical application of FP agonists. 33 This is consistent with previous clinical studies of allosteric FP antagonists that showed no QTc prolongation attributable to drug administration.…”
Section: Discussionmentioning
confidence: 99%
“…In vivo studies have also demonstrated the relevance of FP modulation for cardiac function. Genetic deletion of FP protects against inflammatory tachycardia in mice, and PGF 2α antagonism partly blocks centrally administered arachidonic acid–evoked pressor responses . A clinical study of an FP allosteric inhibitory modulator recorded isolated QT‐interval prolongations that were probably not related to the investigational medical product …”
mentioning
confidence: 99%
See 1 more Smart Citation
“…20 It also modulates ion channels and regulates the activity of many enzymes, including protein kinase A, protein kinase C, and NADPH oxidase. 21 Recently we reported that intracerebroventricularly (ICV) administered AA, by activating the central COX pathway, leads to pressor cardiovascular effects in normotensive [22][23][24] and hemorrhaged hypotensive rats, 25,26 had a hyperventilation effect on respiratory system, 27,28 and stimulation of male hypothalamic-pituitary-gonadal axis. 29 We also reported that inhibition of central COX enzyme completely and blockage of central thromboxane A2 synthesis (TXA2) partially prevented AA-evoked pressor, [22][23][24][25][26] hyperventilation 27,28, and neuroendocrine effects.…”
Section: Introductionmentioning
confidence: 99%